fda warning glutathione injection skin whitening not approved Releases Consumer Update on Injectable Lightening Products FDA highlights concerns with using

10.1186/s12943-020-01258-7 [DOI] [PMC free article] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article

Expanded options for pathway profiling are in the graphic below: Functionality biomarkers Cytochrome P450 enzyme activity Albumin production Urea production Clinical liver health biomarkers Lactose dehydrogenase (LDH) release Adenosine Triphosphate (ATP) Aspartate Transferase (AST)/Alanine amino transferase (ALT) Optional profiling analysis Quantitative PCR Transcriptomics Oxidative stress Mitochondrial dysfunction Steatosis Bile acid synthesis/ transport dysregulation Inflammatory response (Human DILI assay only) Proven predictability, reliability and robustness Using a panel of IQ MPS Consortium-recommended reference compounds, the PhysioMimix DILI assay delivered 100% sensitivity, 85% accuracy and 100% precision, outperforming other in vitro approaches

It is a suitable option for long-term use in maintaining skin health and overall wellness

Whitening